The DOI matches its Crossref record.
Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Doxycycline-inducible EHD3 expression in EHD3-deleted glioblastoma cell lines increases basal levels of EGFR.
“although doxycycline (Dox)-inducible EHD3 expression in EHD3-deleted glioblastoma cell lines increased the basal levels of EGFR (48).”
From EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling (2020) · cites this paper as [48]
EHD3 may function in targeting ligand-stimulated EGFR to lysosomal degradation by diverting it from endocytic recycling.
“A recent study suggested that EHD3 may function in targeting the ligand-stimulated EGFR to lysosomal degradation by diverting it from endocytic recycling (48), consistent with EHD3 deletion in glioblastoma (49), although doxycycline (Dox)-inducible EHD3 expression in EHD3-deleted glioblastoma cell lines increased the basal levels of EGFR (48).”
From EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling (2020) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 59
- Kleihues, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, 114, 97, 10.1007/s00401-007-0243-4 · DOI
- Kesari, 2008, Malignant gliomas in adults, N Engl J Med, 359, 492, 10.1056/NEJMra0708126 · DOI · Paper page
- Network TCGAR, 2008, Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature, 455, 1061, 10.1038/nature07385 · DOI · Paper page
- Cavenee, 2007, Malignant astrocytic glioma: genetics, biology, and paths to treatment, Genes Dev, 21, 2683, 10.1101/gad.1596707 · DOI · Paper page
- Cai, 2010, Therapeutic targeting of EGFR in malignant gliomas, Expert Opin Ther Targets, 14, 303, 10.1517/14728221003598948 · DOI
- White, 2009, Oncogenic EGFR signaling networks in glioma, Sci Signal, 2, re6
- Salgia, 2006, Epidermal growth factor receptor-mediated signal transduction in the development and therapy of gliomas, Clin Cancer Res, 12, 7261, 10.1158/1078-0432.CCR-06-0874 · DOI
- Kandouz, 2014, Ehd3, a regulator of vesicular trafficking, is silenced in gliomas and functions as a tumor suppressor by controlling cell cycle arrest and apoptosis, Carcinogenesis, 35, 877, 10.1093/carcin/bgt399 · DOI
- Caplan, 2005, C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH?, J Cell Sci, 118, 4093, 10.1242/jcs.02595 · DOI · Paper page
- Caplan, 2008, Mechanisms of EHD/RME-1 protein function in endocytic transport, Traffic, 9, 2043, 10.1111/j.1600-0854.2008.00834.x · DOI · Paper page
- Caplan, 2006, Interactions between EHD proteins and Rab11-FIP2: a role for EHD3 in early endosomal transport, Mol Biol Cell, 17, 163, 10.1091/mbc.e05-05-0466 · DOI · Paper page
- Caplan, 2009, EHD3 regulates early-endosome-to-Golgi transport and preserves Golgi morphology, J Cell Sci, 122, 389, 10.1242/jcs.037051 · DOI
- Bunnett, 2009, Endosomes: a legitimate platform for the signaling train, Proc Natl Acad Sci USA, 106, 17615, 10.1073/pnas.0906541106 · DOI · Paper page
- Di Fiore, 2006, Endocytosis conducts the cell signaling orchestra, Cell, 124, 897, 10.1016/j.cell.2006.02.025 · DOI
- Miaczynska, 2009, Signaling from endosomes: location makes a difference, Exp Cell Res, 315, 1601, 10.1016/j.yexcr.2008.09.021 · DOI
- Di Fiore, 2010, The endocytic matrix, Nature, 463, 464, 10.1038/nature08910 · DOI
- von, 2009, Endocytosis and signalling: intertwining molecular networks, Nat Rev Mol Cell Biol, 10, 609, 10.1038/nrm2748 · DOI · Paper page
- Yarden, 2009, Systems biology of growth factor-induced receptor endocytosis, Traffic, 10, 349, 10.1111/j.1600-0854.2008.00870.x · DOI
- Di Fiore, 2008, Endocytosis and cancer: an ‘insider’ network with dangerous liaisons, Traffic, 9, 2011, 10.1111/j.1600-0854.2008.00816.x · DOI · Paper page
- Yarden, 2008, Derailed endocytosis: an emerging feature of cancer, Nat Rev Cancer, 8, 835, 10.1038/nrc2521 · DOI
- Di Fiore, 2004, Endocytosis and cancer, Curr Opin Cell Biol, 16, 156, 10.1016/j.ceb.2004.02.003 · DOI
- Goh, 2009, Endocytosis and intracellular trafficking of ErbBs, Exp Cell Res, 315, 683, 10.1016/j.yexcr.2008.07.029 · DOI
- Caplan, 2011, EHD proteins: key conductors of endocytic transport, Trends Cell Biol, 21, 122, 10.1016/j.tcb.2010.10.003 · DOI · Paper page
- Dikic, 2012, The role of ubiquitylation in receptor endocytosis and endosomal sorting, J Cell Sci, 125, 265, 10.1242/jcs.091280 · DOI
- Habib, 2015, Ligand-Independent EGFR Signaling, Cancer Res, 75, 3436, 10.1158/0008-5472.CAN-15-0989 · DOI
- Zerial, 2004, Not just a sink: endosomes in control of signal transduction, Curr Opin Cell Biol, 16, 400, 10.1016/j.ceb.2004.06.005 · DOI
- Wang, 2002, Internalization of inactive EGF receptor into endosomes and the subsequent activation of endosome-associated EGF receptors. Epidermal growth factor, Sci STKE, 2002, l17, 10.1126/stke.2002.161.pl17 · DOI
- Kuroki, 1986, Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture, Cancer Res, 46, 1648
- Mendelsohn, 1983, Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody, Proc Natl Acad Sci USA, 80, 1337, 10.1073/pnas.80.5.1337 · DOI
- Murayama, 1990, Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice, Ann Surg, 211, 263
- Thomas, 1999, Effects of epidermal growth factor on MDA-MB-468 breast cancer cells: alterations in polyamine biosynthesis and the expression of p21/CIP1/WAF1, J Cell Physiol, 179, 257, 10.1002/(SICI)1097-4652(199906)179:3<257::AID-JCP3>3.0.CO;2-4 · DOI
- Yeudall, 1996, Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells, Oncogene, 12, 2369
- Tartakoff, 1983, Perturbation of vesicular traffic with the carboxylic ionophore monensin, Cell, 32, 1026, 10.1016/0092-8674(83)90286-6 · DOI
- Rowe, 1990, Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity, Biochim Biophys Acta, 1031, 225, 10.1016/0304-4157(90)90008-Z · DOI
- Murphy, 2013, SARA and RNF11 interact with each other and ESCRT-0 core proteins and regulate degradative EGFR trafficking, Oncogene, 32, 5220, 10.1038/onc.2012.554 · DOI
- Anderson, 2015, A kinase-independent role for EGF receptor in autophagy initiation, Cell, 160, 145, 10.1016/j.cell.2014.12.006 · DOI · Paper page
- Hung, 2008, Survival of cancer cells is maintained by EGFR independent of its kinase activity, Cancer Cell, 13, 385, 10.1016/j.ccr.2008.03.015 · DOI
- Wiley, 2001, Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking, Mol Biol Cell, 12, 1897, 10.1091/mbc.12.6.1897 · DOI
- Huitfeldt, 2001, Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF, Eur J Cell Biol, 80, 285, 10.1078/0171-9335-00160 · DOI
- Huber, 2007, Late endosomal traffic of the epidermal growth factor receptor ensures spatial and temporal fidelity of mitogen-activated protein kinase signaling, Mol Biol Cell, 18, 4698, 10.1091/mbc.e07-02-0098 · DOI
- Martin, 1991, Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: correlation with the level of occupied EGF receptor, Anticancer Res, 11, 737
- Berthois, 1994, Relationship between the MAP kinase activity and the dual effect of EGF on A431 cell proliferation, Biochem Biophys Res Commun, 203, 984, 10.1006/bbrc.1994.2279 · DOI
- Berthois, 1996, Regulation of p42 mitogen-activated-protein kinase activity by protein phosphatase 2A under conditions of growth inhibition by epidermal growth factor in A431 cells, Eur J Biochem, 235, 97, 10.1111/j.1432-1033.1996.00097.x · DOI
- Berthois, 1998, Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: evidence for a signal transduction pathway that can bypass Raf-1 activation, Endocrinology, 139, 2382, 10.1210/endo.139.5.5981 · DOI
- Muller, 1985, Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes, EMBO J, 4, 1193, 10.1002/j.1460-2075.1985.tb03759.x · DOI
- Reddy, 1996, Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity, Cell Growth Differ, 7, 173
- Ceresa, 2012, Endosomal accumulation of the activated epidermal growth factor receptor (EGFR) induces apoptosis, J Biol Chem, 287, 712, 10.1074/jbc.M111.294470 · DOI
- Wang, 2003, Stimulation of cell proliferation by endosomal epidermal growth factor receptor as revealed through two distinct phases of signaling, Mol Cell Biol, 23, 5803, 10.1128/MCB.23.16.5803-5815.2003 · DOI
- Wang, 2002, Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival, Mol Cell Biol, 22, 7279, 10.1128/MCB.22.20.7279-7290.2002 · DOI
- Stenmark, 2002, Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes, Nat Cell Biol, 4, 394, 10.1038/ncb791 · DOI · Paper page
- Emr, 2002, Receptor downregulation and multivesicular-body sorting, Nat Rev Mol Cell Biol, 3, 893, 10.1038/nrm973 · DOI · Paper page
- Park, 2003, Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases, Cancer Cell, 3, 519, 10.1016/S1535-6108(03)00136-3 · DOI
- Stenmark, 2009, The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins, Nature, 458, 445, 10.1038/nature07961 · DOI · Paper page
- Borst, 2004, Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment, J Biol Chem, 279, 55465, 10.1074/jbc.M409765200 · DOI
- Madshus, 2004, Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation, Exp Cell Res, 300, 388, 10.1016/j.yexcr.2004.07.003 · DOI
- Yoshimori, 2008, Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation, Mol Biol Cell, 19, 3454, 10.1091/mbc.e07-10-0988 · DOI
- Bindokas, 2013, A function for EHD family proteins in unidirectional retrograde dendritic transport of BACE1 and Alzheimer's disease Abeta production, Cell Rep, 5, 1552, 10.1016/j.celrep.2013.12.006 · DOI · Paper page
- Reist, 1995, Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas, Cancer Res, 55, 3140
- Habib, 2006, Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells, Cancer Res, 66, 867, 10.1158/0008-5472.CAN-05-2753 · DOI · Paper page
Cited by
Sorted by citations
EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling
Tom, E. C., Mushtaq, I., Mohapatra, B. C., Luan, H., Bhat, A. M., Zutshi, N., Chakraborty, S., Islam, N., Arya, P., Bielecki, T. A., et al. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00434-19 · Cited by 13
Metadata
- Authors
- Amessou, M., Ebrahim, A. S., Dilly, A., Joseph, M., Tabolina, M., Chukkapalli, S., Meroueh, L., Syed, J. T., Liddane, A., Lang, S. L., Al-Katib, A., & Kandouz, M.
- Affiliations
- Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan, USA
- Lymphoma Research Lab, Wayne State University School of Medicine, Detroit, Michigan, USA
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-11-01
- Volume
- 7
- Issue
- 48
- Pages
- 79203-79216
- ISSN
- 1949-2553
- PMC
- PMC5346708
- Cited by
- 5
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review